Written by / Agency / Source: Sartorius Stedim Biotech S.A.
Check Ads Availability|e-mail Article

Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!

Sartorius to Demonstrate Special Data Analysis At Night of Knowledge Event Series - How special data analysis helps to make the perfect microwave popcorn is one technology Sartorius will be demonstrating on January 26 from 5:00 pm. to 12:00 am. on Sartorius Campus - NDW.Uni-Goettingen.de / Sartorius.com
Sartorius to Demonstrate Special Data Analysis At Night of Knowledge Event Series

 

NewswireToday - /newswire/ - Göttingen, Lower Saxony, Germany, 2019/01/18 - How special data analysis helps to make the perfect microwave popcorn is one technology Sartorius will be demonstrating on January 26 from 5:00 pm. to 12:00 am. on Sartorius Campus - NDW.Uni-Goettingen.de / Sartorius.com.

   
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Pharma / BioTech / Nutrition Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

As part of the 4th Göttingen Nacht des Wissens the Night of Knowledge event visitors can also use Sartorius pipettes and filters to remove colorants from Fanta Orange sodas, weigh their fingerprints or watch on a live-cell analysis system how tumor cells are destroyed. For the first time, Sartorius will be taking part in the City of Göttingen’s Night of Knowledge event series.

Sartorius staff members will hold presentations on the growing importance of the biopharmaceutical industry for society and laboratories of the future. In addition, visitors will receive information about the company’s history and on how Sartorius products help in the development and manufacture of new medications. This event is free of charge.

To take one of the tours of the Sartorius filter production facilities that will begin every hour, visitors are required to make reservations at ndw.uni-goettingen.de. Shuttle buses will bring visitors to Sartorius Campus and back to the inner city on a regular schedule for free. Visitors can purchase food and beverages on Campus.

About The Sartorius Group

The Sartorius Group (sartorius.com) is a leading international partner of biopharmaceutical research and the industry. With innovative laboratory instruments and consumables, the Group’s Lab Products & Services Division concentrates on serving the needs of laboratories performing research and quality control at pharma and biopharma companies and those of academic research institutes. The Bioprocess Solutions Division with its broad product portfolio focusing on single-use solutions helps customers to manufacture biotech medications and vaccines safely and efficiently. The Group has been annually growing by double digits on average and has been regularly expanding its portfolio by acquisitions of complementary technologies. In fiscal 2017, Sartorius earned sales revenue of more than 1.4billion euros. Currently, more than 8,000 people work at the Group’s approximately 60 manufacturing and sales sites, serving customers around the globe.

 
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Pharma / BioTech / Nutrition Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

Written by / Agency / Source: Sartorius Stedim Biotech S.A.

 
 

Availability: All Regions (Including Int'l)

 

Traffic Booster: [/] Quick Newswire Today Visibility Checker

 

Distribution / Indexing: [+] / [Company listed above is a registered member of our network. Content made possible by PRZOOM / PRTODAY indexing services]

 
 
# # #
 

 
  Your Banner Ad showing on ALL
Pharma / BioTech / Nutrition articles,
CATCH Visitors via Your Competitors Announcements!


Sartorius to Demonstrate Special Data Analysis At Night of Knowledge Event Series

Company website links NOT available to basic submissions
It is OK to republish and/or LINK any newswire for any legitimate media purpose as long as you name Newswire Today and LINK as the source.
 
Publisher Contact: Timo Lindemann - Sartorius.com 
+49(0)551.308.4724 timo.lindemann[.]sartorius.com
 
Newswire Today - PRZOOM / PRTODAY disclaims any content contained in this article. If you need/wish to contact the company who published the current release, you will need to contact them - NOT us. Issuers of articles are solely responsible for the accuracy of their content. Our complete disclaimer appears here.
IMPORTANT INFORMATION: Issuance, publication or distribution of this press release in certain jurisdictions could be subject to restrictions. The recipient of this press release is responsible for using this press release and the information herein in accordance with the applicable rules and regulations in the particular jurisdiction. This press release does not constitute an offer or an offering to acquire or subscribe for any Sartorius Stedim Biotech S.A. securities in any jurisdiction including any other companies listed or named in this release.

Pharma / BioTech / Nutrition via RSSAdd NewswireToday - PRZOOM Headline News to FeedBurner
Find who RetweetFollow @NewswireTODAY

Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!


Read Latest Articles From Sartorius Stedim Biotech S.A. / Company Profile


Read Pharma / BioTech / Nutrition Most Recent Related Newswires:

Andrew Alliance and Sartorius Collaborate to Provide Software-Connected Pipettes for Life Science Research
NHS England Expands Loco-regional Treatment Options for Colorectal Cancer Patients with Metastatic Disease
Sartorius Joins the Community of the National Institute for Innovation in Manufacturing Biopharmaceuticals (NIIMBL)
DSM Announces JV with Nenter to Produce Vitamin E
The Lake Norman Chamber of Commerce Recognizes Huntersville Physician Dr. John Powderly
STEMCELL Technologies Launches mTeSR™ Plus - A Next-Generation Culture System for Human ES and iPS Cell Maintenance
Sartorius Stedim Biotech Launches Services for Characterization of New Biological Entities (NBE)
Sartorius Stedim Biotech Introduces BIOSTAT® RM TX with Flexsafe® RM TX for Producing Consistent Quality Cellular Products
FDA Accepts Genentech’s Supplemental Biologics License Application for Tecentriq Plus Chemotherapy (Abraxane and Carboplatin)
Cell Therapy Market to Grow Beyond Oncology As Big Pharma Expands Investments Finds Frost & Sullivan
Bioquark, Inc. and Ectocrine Technologies, LLC to Collaborate on Mosquito-Derived Health Products
BTG and OMNY Partner to Improve Treatment of Snake Bite Victims
FDA Approves Genentech’s Tecentriq in Combination with Avastin and Chemotherapy
Exelixis and Ipsen Initiate Phase 3 Pivotal Trial of Cabozantinib in Combination with Atezolizumab Versus Sorafenib
Ipsen and 3BP Announce First Patient Dosed in Phase I/II study for First-in-Class Radionuclide (IPN01087)

Boost Your Social Network
& Crowdfunding Campaigns


LIFETIME SOCIAL MEDIA WALL
NewswireToday Celebrates 10 Years in Business


PREMIUM Members


Visit  JobsWare.com

Visit  BizJobs.com





 
  ©2019 Newswire Today Limelon Advertising, Co.
Home | About | Advertise/Pricing | Contact | Investors | Privacy/TOS | Sitemap | FRANCAIS
newswire, PR press releases distribution service magazines engine news alert newsroom press room breaking news public relations articles company news alerts newswiredistribution ezine bizentrepreneur biznewstoday digital business report market search pr firms agencies reports distri-bution today investor relation successful internet entrepreneurs newswire distribution prtoday.com newswiredistribution asianewstoday bizwiretoday USA pr UK today - NOT affiliated with PRNewswire as we declined their partnership offer in 2013
 
PRTODAY & NewswireTODAY are NOT affiliated with USA TODAY (usatoday.com)